Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued to investors on Monday. The brokerage issued a hold rating on the stock.

Milestone Scientific Stock Down 1.0 %

MLSS opened at $0.97 on Monday. The stock has a market capitalization of $74.91 million, a price-to-earnings ratio of -9.70 and a beta of 1.08. Milestone Scientific has a twelve month low of $0.52 and a twelve month high of $1.10. The company has a 50-day simple moving average of $0.97 and a 200 day simple moving average of $0.78.

Milestone Scientific (NYSE:MLSS) last posted its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.01). Milestone Scientific had a negative return on equity of 60.78% and a negative net margin of 54.87%. The firm had revenue of $1.85 million for the quarter.

Insider Transactions at Milestone Scientific

In related news, Director Leonard Osser sold 141,913 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $0.95, for a total value of $134,817.35. Following the sale, the director now directly owns 4,602,506 shares of the company’s stock, valued at $4,372,380.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 24.75% of the stock is owned by insiders.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.